Evaluating heart recovery after surgery for aortic regurgitation
Official title: Left Ventricular Reverse Remodeling Outcomes Evaluation in Patients With Aortic Regurgitation After Surgical Treatment
Run by Petrovsky National Research Centre of Surgery · NCT06805253 · Data updated 2026-11-12
This study looks at how heart surgery for aortic regurgitation helps people with heart problems feel better and recover by checking their heart function and quality of life afterward.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 120 (estimated) |
| Sponsor | Petrovsky National Research Centre of Surgery Academic / other |
| Locations | 2 sites (Moscow and 1 other locations) |
| Status | Recruiting |
| Started | May 9, 2024 |
| Main results expected | May 2029 |
| Study ends | May 2030 |
| Registry record updated | June 11, 2025 |
| Trial ID | NCT06805253 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are adults over 18 years scheduled for elective surgery due to chronic aortic regurgitation with functional mitral regurgitation.
✕Probably not a fit
Patients with acute aortic regurgitation, infectious endocarditis, or those requiring simultaneous myocardial revascularization may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study investigates the effects of surgical correction for chronic aortic regurgitation on the reverse remodeling of the left ventricle in patients with functional mitral regurgitation. It aims to monitor changes in left ventricle volume and function post-surgery using echocardiography, while also assessing the quality of life in participants. The study focuses on patients with severe enlargement of the left heart chambers and evaluates how surgical intervention influences recovery outcomes.
Why it matters
Potential benefit: If successful, this study could lead to improved recovery strategies for patients undergoing surgery for aortic regurgitation, enhancing heart function and quality of life.
How similar studies have gone: While this approach is observational, similar studies have shown promising results in understanding heart recovery post-surgery, suggesting potential for beneficial insights.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Age over 18 years * Planned primary elective surgery for chronic aortic regurgitation * Presence of functional mitral regurgitation * End-diastolic volume of the left ventricle \>= 250 ml Exclusion Criteria: * Infectious endocarditis * History of myocardial infarction * Indications on simultaneous myocardial revascularisation * Acute aortic regurgitation of any etiology * Previously diagnosed dilatation of the left ventricle, not associated with the development of aortic regurgitation * Long-term persistent or permanent form of atrial fibrillation * Pregnancy in the first 12 months after surgery * Simultaneous participation in other studies * Presence of implanted pacemakers * Refusal to sign informed consent * Acute coronary event diagnosed within 12 months after aortic valve surgery * Indications for resynchronization therapy or permanent right ventricular pacing in the first 12 months after aortic valve surgery * Re-do cardiac surgery for any reason within 12 months after aortic valve surgery
Where it's running
-
Petrovsky National Research Center of Surgery
Moscow, Russia Recruiting -
Voronezh Regional Clinical Hospital No. 1
Voronezh, Russia Recruiting
Study contacts
- Study coordinator: Eduard Charchyan, professor
- Email: charchmed@yahoo.com
- Phone: +79262174114
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
How TAVI and M‑TEER affect sleep‑disordered breathing
This will see if adults with aortic stenosis or mitral regurgitation who undergo TAVI or M‑TEER have improvements in sleep‑disordered breathing six months after their procedure.
-
Mitral and Tricuspid Valve-in-Valve/Valve-in-Ring Registry in Asia-Pacific
This registry tracks people in Asia-Pacific who have had or will have valve-in-valve or valve-in-ring procedures for mitral or tricuspid valve disease to learn about outcomes and safety after these transcatheter approaches.
-
Tracking progression and consequences of heart valve disease
This project will follow adults with moderate or worse valve disease to see if clinical tests and imaging can predict when their condition will get worse.
-
Less invasive ventricular enhancement using the Revivent System
This trial tests whether adding the Revivent structural repair system to standard heart-failure medicines helps people with weakened, dilated left ventricles and an anterior/apical scar or aneurysm.
-
Evaluation of the AltaValve System for treating mitral regurgitation
This study is testing a new device called the AltaValve System to see if it can help people with mitral regurgitation who can't have surgery feel better and improve their heart function.
-
Evaluating Transcatheter Aortic Valve Replacement for Severe Aortic Valve Regurgitation
This study is testing if a less invasive heart valve replacement procedure can safely help people with severe aortic valve regurgitation feel better.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.